On eve of biggest biotech IPO this year, 2 East Bay companies spar over patents

10X Genomics is one of the hottest life sciences companies, hitting the market today after an expected $448.5 million IPO. But Bio-Rad Laboratories claims 10X’s products are based on patents it holds.